论文部分内容阅读
根据1976年12月第二次协作会议的要求,决定由上海医药工业研究院和遵义医学院在遵义组织动物肿瘤模型会战,就肿节风对Ca615(上海医工院肿瘤模型)及TM755(遵医肿瘤模型)两个瘤株的治疗效应共同进行复核,并用另一新模型RS615(遵医建立)共同进行药理筛选。1977年3月18日始至7月7日结束,共做了六批治疗实验(计Ca615三批,TM755二批,RS615一批),连同协作会议后遵医用RS615所做的一批,总计七批实验。初步结果表明:(1)肿节风干浸膏在三个瘤株的七批实验中有六批(三个瘤株各两批)出现
According to the requirements of the second coordination meeting in December 1976, it was decided that the Shanghai Institute of Pharmaceutical Industry and Zunyi Medical College would organize an animal tumor model battle in Zunyi, and that Tumorous Wind would affect Ca615 (Shanghai Institute of Medical Sciences tumor model) and TM755 (compliance). Medical tumor models) The therapeutic effects of the two tumor strains were reviewed together, and pharmacological screening was performed using another new model, RS615 (established by the doctor). From March 18, 1977 to July 7, a total of six batches of treatment trials (three batches of Ca 615, two batches of TM 755, and one batch of RS 615) were performed, together with a batch of medical RS 615 that were performed following the collaborative session. Seven batches of experiments. The preliminary results showed that: (1) There were six batches of three swollen air-dried extracts in three batches of three tumor lines (two batches of three tumor lines)